The interests of our research group span the disciplines of organic synthesis, asymmetric catalysis, peptide drug design computational chemistry and pharmacology. Current projects are:
- Synthesis and evaluation of inhibitors targeting HIV and TB
- Synthesis of classes of chiral ligands and catalysts
- Experimental and theoretical research about the fundamental aspects of peptide folding
- Various computational projects into mechanistic effects of our synthetic projects.